Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Yan

Showing results (581-590 of 630) with videos related to

Pageof 63
Sort By:
American Heart Journal|November 14, 2017
Does renal function affect the efficacy or safety of a pharmacoinvasive strategy in patients with ST-elevation myocardial infarction? A meta-analysisJuan J Russo, Shaun G Goodman, Warren J Cantor, et al.
JACC. Cardiovascular Interventions|January 25, 2015
Relationship between time to invasive assessment and clinical outcomes of patients undergoing an early invasive strategy after fibrinolysis for ST-segment elevation myocardial infarction: a patient-level analysis of the randomized early routine invasive clinical trialsMina Madan, Sigrun Halvorsen, Carlo Di Mario, et al.
The American Journal of Cardiology|August 18, 2018
Previous and New Onset Atrial Fibrillation and Associated Outcomes in Acute Coronary Syndromes (from the Global Registry of Acute Coronary Events)Mali D Worme, Mary K Tan, David W J Armstrong, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|December 18, 2018
Cardiovascular magnetic resonance left ventricular strain in end-stage renal disease patients after kidney transplantationInna Y Gong, Bandar Al-Amro, G V Ramesh Prasad, et al.
JACC. Cardiovascular Imaging|January 17, 2021
Empagliflozin Reduces Myocardial Extracellular Volume in Patients With Type 2 Diabetes and Coronary Artery DiseaseTamique Mason, Otavio R Coelho-Filho, Subodh Verma, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 4, 2006
XRCC4 suppresses medulloblastomas with recurrent translocations in p53-deficient miceCatherine T Yan, Dhruv Kaushal, Michael Murphy, et al.
Bioorganic & Medicinal Chemistry Letters|December 20, 2003
(2-amino-phenyl)-amides of omega-substituted alkanoic acids as new histone deacetylase inhibitorsArkadii Vaisburg, Naomy Bernstein, Sylvie Frechette, et al.
Cell Metabolism|September 4, 2019
SGLT2 Inhibition with Empagliflozin Increases Circulating Provascular Progenitor Cells in People with Type 2 Diabetes MellitusDavid A Hess, Daniella C Terenzi, Justin Z Trac, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|March 23, 2020
Effects of Empagliflozin on Left Ventricular Remodeling in Patients with Type 2 Diabetes and Coronary Artery Disease: Echocardiographic Substudy of the EMPA-HEART CardioLink-6 Randomized Clinical TrialKaran Bami, Sumeet Gandhi, Howard Leong-Poi, et al.
Circulation|November 12, 2019
Effect of Empagliflozin on Erythropoietin Levels, Iron Stores, and Red Blood Cell Morphology in Patients With Type 2 Diabetes Mellitus and Coronary Artery DiseaseC David Mazer, Gregory M T Hare, Philip W Connelly, et al.
Pageof 63

Showing results (581-590 of 630) with videos related to

Sort By:
Pageof 63
American Heart Journal|November 14, 2017
Does renal function affect the efficacy or safety of a pharmacoinvasive strategy in patients with ST-elevation myocardial infarction? A meta-analysisJuan J Russo, Shaun G Goodman, Warren J Cantor, et al.
JACC. Cardiovascular Interventions|January 25, 2015
Relationship between time to invasive assessment and clinical outcomes of patients undergoing an early invasive strategy after fibrinolysis for ST-segment elevation myocardial infarction: a patient-level analysis of the randomized early routine invasive clinical trialsMina Madan, Sigrun Halvorsen, Carlo Di Mario, et al.
The American Journal of Cardiology|August 18, 2018
Previous and New Onset Atrial Fibrillation and Associated Outcomes in Acute Coronary Syndromes (from the Global Registry of Acute Coronary Events)Mali D Worme, Mary K Tan, David W J Armstrong, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|December 18, 2018
Cardiovascular magnetic resonance left ventricular strain in end-stage renal disease patients after kidney transplantationInna Y Gong, Bandar Al-Amro, G V Ramesh Prasad, et al.
JACC. Cardiovascular Imaging|January 17, 2021
Empagliflozin Reduces Myocardial Extracellular Volume in Patients With Type 2 Diabetes and Coronary Artery DiseaseTamique Mason, Otavio R Coelho-Filho, Subodh Verma, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 4, 2006
XRCC4 suppresses medulloblastomas with recurrent translocations in p53-deficient miceCatherine T Yan, Dhruv Kaushal, Michael Murphy, et al.
Bioorganic & Medicinal Chemistry Letters|December 20, 2003
(2-amino-phenyl)-amides of omega-substituted alkanoic acids as new histone deacetylase inhibitorsArkadii Vaisburg, Naomy Bernstein, Sylvie Frechette, et al.
Cell Metabolism|September 4, 2019
SGLT2 Inhibition with Empagliflozin Increases Circulating Provascular Progenitor Cells in People with Type 2 Diabetes MellitusDavid A Hess, Daniella C Terenzi, Justin Z Trac, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|March 23, 2020
Effects of Empagliflozin on Left Ventricular Remodeling in Patients with Type 2 Diabetes and Coronary Artery Disease: Echocardiographic Substudy of the EMPA-HEART CardioLink-6 Randomized Clinical TrialKaran Bami, Sumeet Gandhi, Howard Leong-Poi, et al.
Circulation|November 12, 2019
Effect of Empagliflozin on Erythropoietin Levels, Iron Stores, and Red Blood Cell Morphology in Patients With Type 2 Diabetes Mellitus and Coronary Artery DiseaseC David Mazer, Gregory M T Hare, Philip W Connelly, et al.
Pageof 63